DCVC | Vium

First Investment: 2014

EXIT - Acquisition (Recursion: RXRX)

Vium combined computer vision, machine learning, and sensor technology to build “digital vivariums” that collected noninvasive data on the health of animals used in preclinical research. Recursion acquired the company in 2020.

Explore Companies

Newleos Therapeutics

Transforming the treatment of anxiety and other neuropsychiatric disorders

Grove Biopharma

Putting protein-like drugs inside cells to fight cancer and neurodegeneration

Syntax Bio

Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics

Using state-of-the-art machine learning models to create custom-build protein drugs